IMAC IMAC Holdings

IMAC Partners with Fortune 500 Company to Launch In-Store Spinal Care

IMAC Partners with Fortune 500 Company to Launch In-Store Spinal Care

 The Back Space will deliver chiropractic and spinal care services in a multi-store test market

BRENTWOOD, Tenn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), today announced a strategic partnership with a Fortune 500 company by launching its new wholly-owned subsidiary The Back Space, LLC (). The Back Space will operate retail healthcare centers specializing in chiropractic and spinal care services inside the partner’s locations. The first location is scheduled to open in April.

The Back Space will specialize in treatments for back and neck pain, soft-tissue recovery, muscle tension and spinal wellness while providing chiropractic adjustments, nerve and muscle stimulation, and percussion tool therapies. Each service will be priced at $25 or less per treatment with memberships available for $65 per month.

“We have witnessed a strong demand for spinal care in our IMAC locations and The Back Space will provide convenient and affordable treatments for the 60 million Americans that suffer from back or neck pain,” said Matt Wallis, Chief Operating Officer of IMAC Holdings. “We are excited to launch The Back Space because helping people get back to living their best life is IMAC’s purpose,” he added.

The Back Space will initially open at least five locations as part of a test market with the Fortune 500 partner. The stores will average 800 square feet and require minimal structural and equipment investment to open for customers.

According to the United States Chiropractic Association, back pain is the single leading cause of disability worldwide and is the most common reason reported for missed work. Experts estimate that up to 80 percent of the population will experience back pain at some point in their lives, regardless of their age, gender or economic status.

“The Back Space has the ability to scale quickly after the concept is proven during the test market period,” stated Jeffrey Ervin, IMAC Holdings’ Chief Executive Officer. “This initiative complements our medical clinics, providing another point of entry for consumers with chronic pain that require further medical assistance. I am very excited about the progress we have made to execute our business development initiatives in 2021,” he concluded.

The U.S. chiropractic market has been estimated at approximately $12.3 billion in 2017 with a compound annual growth rate of 4.3 percent, according to Grand View Research. IMAC believes the trends point increasingly to chiropractic therapy gaining acceptance for its cost-saving advantages compared to traditional methods of pain diagnosis utilizing prescription medications and surgical intervention.

About IMAC Holdings, Inc.

IMAC was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life-science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages more than 15 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes including Ozzie Smith, David Price, Mike Ditka and Tony Delk. IMAC’s outpatient medical clinics emphasize treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids. More information about IMAC Holdings, Inc. is available at .

# # #

Safe Harbor Statement

This press release contains forward-looking statements. These forward-looking statements, and terms such as “anticipate,” “expect,” “believe,” “may,” “will,” “should” or other comparable terms, are based largely on IMAC’s expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC’s control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with the launch of IMAC’s new strategic partnership, its ability to grow its business nationwide in 2021 and 2022, its ability to enhance its brand to consumers, its development and introduction of new healthcare products and services, its successful integration of acquired chiropractic and other companies, technologies and assets, its ongoing marketing and other business development initiatives, competition in the rehabilitation and regenerative industry, new and changing healthcare government regulation, its ability to protect its intellectual property, and its ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers’ requirements. IMAC encourages you to review other factors that may affect its future results in the public filings that it makes with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.

IMAC Press Contact:

Laura Fristoe

Investor Relations:

Bret Shapiro

(516) 222-2560



EN
25/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMAC Holdings

 PRESS RELEASE

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirement...

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements Franklin, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced that it has received notice from The Nasdaq Stock Market LLC informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market and that it is in compliance with all applicable listing standards. The Company’s common stock and warrants will continue to be listed and traded on The N...

 PRESS RELEASE

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split Franklin, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 (the “Reverse Split”) and that it had filed a Certificate of Amendment to the Company’s Certificate of Incorporation in order to effect the Reverse Split. The Reverse Split will be effective after the market closes on September 7, 2023. Beginning with the opening of trading on September 8, 2023, the Company’s common stock...

 PRESS RELEASE

IMAC Holdings Announces $4.3 Million Private Placement of Convertible ...

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market Franklin, Tennessee, July 26, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, announced today that it entered into a definitive securities purchase agreement with several institutional and accredited investors, including existing significant investors of Theralink Technologies, Inc., its previously announced merg...

 PRESS RELEASE

IMAC Holdings Annual Meeting of Shareholders Reminder

IMAC Holdings Annual Meeting of Shareholders Reminder Shareholders are reminded to vote their shares prior to the proxy voting deadline of 7:00pm on July 4, 2023 FRANKLIN, Tenn., June 28, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, reminds its shareholders that its Annual Meeting will be held July 5, 2023 at 11:00 am, local time, in Franklin, Tennessee. IMAC shareholders are encouraged to read the Proxy ...

 PRESS RELEASE

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Ho...

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company Theralink’s patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict FDA-approved drugs that may be effective in each solid tumor cancer Golden, Colorado, May 23, 2023 (GLOBE NEWSWIRE) -- , Inc. (OTC: THER) (“Theralink”) and IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), today announced that they have entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) under which Theralink will merg...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch